<!doctype html>
<html lang="en-US">
  <head>
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width" />
    <title> Health Information News:August 2025 Edition </title>
    <link href="styles/style.css" rel="stylesheet" />
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:ital,wght@0,400..900;1,400..900&display=swap" rel="stylesheet">
  </head>
  <body>
    <h1> Health Information News:<br>August 2025 Edition </h1>
    <p> Welcome to the August 2025 Edition of Health Information News. Join us for the newest developments in Health IT.
        Our readers are scientists, educators, researchers, students, and ethusiasts in the global health information community. </p>
    <img src="images/health_it_graphic.jpg" alt="Health IT Graphic" />
    <h2> FDA removes emergency clearance of Pfizer-BioNTech COVID-19 vaccine for children under 5 </h2>
    <p> The U.S. Food and Drug Administration (FDA) has removed the emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine for children under 5 years old. This decision comes after a thorough review of recent data indicating that the vaccine's benefits no longer outweigh the risks for this age group. Parents are advised to consult with their pediatricians for alternative protective measures against COVID-19. </p>
    <h2>CDC director Susan Monarez ousted from position as Director of the Centers for Disease Control and Prevention </h2>
    <p> In a surprising move, Susan Monarez has been removed from her position as Director of the Centers for Disease Control and Prevention (CDC). The decision was made by the Department of Health and Human Services following internal reviews of the agency's handling of recent public health crises. An interim director will be appointed while a search for a permanent replacement is conducted. 
        The removal of Monarez has triggered a wave of resignations from senior staff members, raising concerns about the future direction of the CDC. Jim O'Neill, STEM investor and United States Deputy Secretary of Health and Human Services, has been appointed as the interim director.
    </p>
    <h2> Pediatric oncology clinical trials respond to funding cuts </h2>
    <p> Pediatric oncology clinical trials are facing significant challenges due to recent funding cuts. Researchers and healthcare providers are working tirelessly to adapt to the new financial landscape, seeking alternative funding sources and partnerships to continue their vital work. The impact of these cuts is being felt across the board, with delays in trial initiation and reduced patient enrollment. Advocacy groups are calling for increased support to ensure that advancements in pediatric cancer treatment are not hindered. </p>
    <footer>
      <small>
        Sources: NBC News, The New York Times, Health IT News
      </small>
    </footer>
  </body>
</html> 